| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 2007;49:740.)
© 2007 American Heart Association, Inc.
Brief Reviews |
From the Research Centre, Centre Hospitalier de lUniversité de Montréal, lUniversité de Montréal Montréal, Québec, Canada.
Correspondence to Alan Y. Deng, Research Centre, Centre Hospitalier de lUniversité de Montréal, Technopôle Angus, 2901 Rachel St East, Room 312, Montréal, Québec H1W 4A4, Canada. E-mail alan.deng@umontreal.ca
An extract of the first 250 words of the full text is provided, because this article has no abstract. |
| Introduction |
|---|
Because existing human populations are genetically heterogeneous, and because environmental factors impacting on the pathogenesis of hypertension cannot be controlled in a given population, it is difficult to identify the molecular mechanisms that transduce the sequela of essential hypertension via direct human studies.3 To alleviate the drawbacks of human investigations, animal models, especially inbred rodents, have been developed and experimentally manipulated to identify quantitative trait loci (QTLs) for BP, because major confounding environmental factors, such as diet and genetic background, can be systematically controlled. Once identified in animal models, the molecular basis may be translated into physiological understandings of essential hypertension in humans.
It is with this expectation that efforts have been launched to identify the molecular basis of BP QTLs in animal models. Because the identification of individual QTLs is primarily based on their chromosome locations unbiased by, or unrestricted to, their physiological roles, positional cloning is believed to be the most efficient strategy.
Before we embark on discussions regarding QTL discovery, a definition is in order. Semantic arguments abound as to exactly what a QTL, that is, a locus,4 entails. Is it 1 gene or a collection of
This article has been cited by other articles:
![]() |
G. T. Cicila, E. E. Morgan, S. J. Lee, P. Farms, S. Yerga-Woolwine, E. J. Toland, R. S. Ramdath, K. Gopalakrishnan, K. Bohman, A. L. Nestor-Kalinoski, et al. Epistatic Genetic Determinants of Blood Pressure and Mortality in a Salt-Sensitive Hypertension Model Hypertension, April 1, 2009; 53(4): 725 - 732. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. H. Lee, B. J. Haas, N. E. Letwin, B. C. Frank, T. V. Luu, Q. Sun, C. D. House, S. Yerga-Woolwine, P. Farms, E. Manickavasagam, et al. Cross-Talk of Expression Quantitative Trait Loci Within 2 Interacting Blood Pressure Quantitative Trait Loci Hypertension, December 1, 2007; 50(6): 1126 - 1133. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Saad, S. Yerga-Woolwine, J. Saikumar, P. Farms, E. Manickavasagam, E. J. Toland, and B. Joe Congenic Interval Mapping of RNO10 Reveals a Complex Cluster of Closely-Linked Genetic Determinants of Blood Pressure Hypertension, November 1, 2007; 50(5): 891 - 898. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Y. Deng Genetic basis of polygenic hypertension Hum. Mol. Genet., October 15, 2007; 16(R2): R195 - R202. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. S. Huang, M. Ahmad, A. Y. Deng, and F. H.H. Leenen Neuronal Responsiveness to Central Na+ in 2 Congenic Strains of Dahl Salt-Sensitive Rats Hypertension, June 1, 2007; 49(6): 1315 - 1320. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2007 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |